PREGNACARE®

Pregnacare® by Vitabiotics, is a popular and trusted pregnancy micronutrient supplement which is now available in South Africa.  Vitabiotics was voted Britain’s No. 1 vitamin supplement company in 2013 and is Britain’s best selling range of vitamins.  It also received the Queen’s Award for “Enterprise in Innovation in Vitamin Research”.

Pregnacare® Conception tablets are a micronutrient supplement carefully developed by experts to incorporate all the important vitamins and minerals at safe levels for becoming pregnant.  Each tablet contains 400mg of folic acid which is the required amount for women trying to conceive.  *Clinical trials have proven it is effective in women as it increases the chance of falling pregnant and also cuts the risk of having a premature baby by up to 70%. 

Pregnacare® is a scientifically developed formulation of 19 important vitamins and minerals and contains vitamin B12 and folic acid at the exact level recommended by the health experts.  Throughout pregnancy and breast-feeding, Pregnacare® should be taken to ensure the health of mother and baby in utero.  *Clinical trials conducted, were based on 402 pregnant women.

Pregnacare® Plus has even greater nutritional care for mums-to-be.  Each pack contains 28 Pregnacare® tablets with all the recommended vitamins and nutrients from pre-conception, during pregnancy and through to the end of breast feeding.   Plus it includes 300 mg of DHA (DHA plays an essential role in the healthy development of the brain, nervous system and eyes in the foetus and newborn infants) in Omega-3 capsules sourced from pure Norwegian fish oil.

Pregnacare® Stretch Cream is a formulation of natural botanical plant extracts and should be  applied liberally to stomach, waist, thighs and breasts in order to maintain the skin’s elasticity pre, during and post pregnancy. 

All products are available from www.vitabiotics.co.za and major wholesalers.

*Pregnacare® Conception Clinical Trials conducted by: Dr. Rina Agrawal MD, MRCOG, PhD Consultant & Hon. Associate Professor in Reproductive Medicine and Obstetrics & Gynaecology, University Hospitals of Warwickshire & Warwick University, Formerly University College London, The Portland Hospital and The London Clinic Clinical trials: University of Texas, based on 38,033 women.
 (Received 14 May 2011; refereed 30 September 2011; accepted 6 October 2011.)

Pregnacare® Clinical Trials conducted byLouise Brough1*, Gail A. Rees2, Michael A. Crawford3, R. Hugh Morton1 and Edgar K. Dorman4
1Institute of Food Nutrition and Human Health, Massey University, Palmerston North, New Zealand, Massey University, Private  Bag 11222, Palmerston North, New Zealand 2 School of Biological Sciences, University of Plymouth, Drake Circus, Plymouth PL4 8AA, UK
3 Institute of Brain Chemistry and Human Nutrition, London Metropolitan University, 166-220 Holloway Road, London N7 8DB, UK
4Homerton University Hospital, Homerton Row, London E9 6SR, UK
(Received 16 September 2009 – Revised 5 January 2009 – Accepted 9 February 2010)